Company intelligence / Profile preview

Northpond Ventures

Cambridge, Massachusetts, United Statesnpv.vc ↗

Ownership: Private
Development stage: Other

Overview

Northpond Ventures does not conduct clinical trials or report clinical results directly. Its portfolio includes numerous biotech firms at various stages from preclinical to late-stage clinical development.

Therapeutic areas: Other
Modalities: Not applicable (as an investor/VC firm; invests in companies working with a wide range of modalities including Small molecule, Monoclonal antibody, Gene therapy, Cell therapy, RNA therapy and more through its portfolio)
Industry: Investors

Partnerships

Collaborates with leading academic institutions for translational research funding and company formation support via "Northpond Labs"

Beyond the preview

Go deeper on Northpond Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Northpond Ventures.

Explore the full profile